A Pill to Reclaim Your Hearing? Breakthrough Targets a Silent Epidemic

A newly patented supplement, ACEMg, is the first clinically proven to preserve or improve hearing.
Research links the supplement to a reduced risk of dementia in individuals with hearing loss.
The breakthrough could revolutionize hearing health for the 1.5 billion people affected worldwide.

For billions, the world is slowly fading into silence. Sensorineural hearing loss (SNHL) is a global epidemic, and its devastating link to cognitive decline and dementia is a growing fear for many². But what if a simple, daily supplement could turn back the tide?

Enter ACEMg, a revolutionary nutraceutical from Public Benefit Corporation Soundbites. Backed by decades of auditory research and secured by a new U.S. patent, ACEMg is the first-ever supplement clinically proven to preserve or even improve hearing. Clinical studies show that daily use can improve hearing thresholds by an incredible 15% or more^{2, 3}.

The implications are staggering. The patent extends to claims that ACEMg can lower the severity or risk of dementia and Alzheimer's disease in at-risk individuals with hearing loss³. Hailed as a potential advancement on par with the hearing aid, this innovation isn't just about turning up the volume—it's about protecting the brain and preserving a person's connection to the world. With four more patents in the pipeline, Soundbites is signalling a new dawn in the fight against one of modern life’s most formidable challenges⁴.

A Pill to Reclaim Your Hearing? Breakthrough Targets a Silent Epidemic

References

Stay Updated!